skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Publisher or Other Site remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections
Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections

Edwards, Steven J. ; Emmas, Cathy E. ; Campbell, Helen E.

Current medical research and opinion, 2005-05, Vol.21 (5), p.785-794 [Periódico revisado por pares]

England: Informa UK Ltd

Texto completo disponível

Citações Citado por
2
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination

Mansour, Hanine ; Ouweini, Ahmad E L ; Chahine, Elias B ; Karaoui, Lamis R

American journal of health-system pharmacy, 2021-03, Vol.78 (8), p.674-683 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
3
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial

Kim, Jong Wook ; Chung, Joowon ; Choi, Sang-Ho ; Jang, Hang Jea ; Hong, Sang-Bum ; Lim, Chae-Man ; Koh, Younsuck

Critical care (London, England), 2012-02, Vol.16 (1), p.R28-R28 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study

Sanz, Miguel A. ; Bermúdez, Arancha ; Rovira, Montserrat ; Besalduch, Juan ; Pascual, Maria-Jesus ; Nocea, Gonzalo ; Sanz-Rodríguez, César

Current medical research and opinion, 2005-05, Vol.21 (5), p.645-655 [Periódico revisado por pares]

England: Taylor & Francis

Texto completo disponível

Citações Citado por
5
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study

Vazquez, José A. ; González Patzán, Luis Demetrio ; Stricklin, David ; Duttaroy, Dipesh D. ; Kreidly, Zouheir ; Lipka, Joy ; Sable, Carole

Current medical research and opinion, 2012-12, Vol.28 (12), p.1921-1931 [Periódico revisado por pares]

England: Informa UK Ltd

Texto completo disponível

Citações Citado por
6
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study The results herein were presented in part at the XLIV Annual Meeting of the Spanish Society for Hematology and Hemotherapy (AEHH), Tarragona, Spain, 17–19 October, 2002
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study The results herein were presented in part at the XLIV Annual Meeting of the Spanish Society for Hematology and Hemotherapy (AEHH), Tarragona, Spain, 17–19 October, 2002
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study The results herein were presented in part at the XLIV Annual Meeting of the Spanish Society for Hematology and Hemotherapy (AEHH), Tarragona, Spain, 17–19 October, 2002

Sanz, Miguel A. ; Bermúdez, Arancha ; Rovira, Montserrat ; Besalduch, Juan ; Pascual, Maria-Jesus ; Nocea, Gonzalo ; Sanz-Rodríguez, César

Current medical research and opinion, 2005-05, Vol.21 (5), p.645-655 [Periódico revisado por pares]

Informa UK Ltd

Texto completo disponível

Citações Citado por
7
Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence
Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence

Tejedor, A ; Torres, A M ; Castilla, M ; Lazaro, J A ; de Lucas, C ; Caramelo, C

Current medical research and opinion, 2007-03, Vol.23 (3), p.505 [Periódico revisado por pares]

England: Informa Healthcare

Texto completo disponível

Citações Citado por
8
LABORATORY AND CLINICAL STUDIES ON IMIPENEM/CILASTATIN SODIUM PLUS AMIKACIN SULFATE IN PATIENTS WITH SEVERE INFECTIONS COMPLICATING HEMATOLOGICAL DISORDERS
LABORATORY AND CLINICAL STUDIES ON IMIPENEM/CILASTATIN SODIUM PLUS AMIKACIN SULFATE IN PATIENTS WITH SEVERE INFECTIONS COMPLICATING HEMATOLOGICAL DISORDERS
Material Type:
Artigo 		Adicionar ao Meu Espaço

LABORATORY AND CLINICAL STUDIES ON IMIPENEM/CILASTATIN SODIUM PLUS AMIKACIN SULFATE IN PATIENTS WITH SEVERE INFECTIONS COMPLICATING HEMATOLOGICAL DISORDERS

HOTTA, TOMOMITSU ; MORISHIMA, YASUO ; SAITO, HIDEHIKO ; KODERA, YOSHIHISA ; HIRABAYASHI, NORIYUKI ; TANAKA, MASAO ; MIZUNO, HARUMITSU ; SUZUKI, HISAMITSU ; KATO, YUKIO ; MORISHITA, YOSHIHISA ; NISHIWAKI, HIROSHI ; NAITO, KAZUYUKI ; TOKORO, KIWAMU ; UTSUMI, MAKOTO

The Japanese Journal of Antibiotics, 1991/05/25, Vol.44(5), pp.515-528 [Periódico revisado por pares]

Japan: Japan Antibiotics Research Association

Texto completo disponível

Citações Citado por
9
The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone–cements: A pharmacokinetic study
The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone–cements: A pharmacokinetic study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone–cements: A pharmacokinetic study

Cerretani, Daniela ; Giorgi, Giorgio ; Fornara, Paolo ; Bocchi, Luigi ; Neri, Laura ; Ceffa, Remo ; Ghisellini, Franco ; Ritter, Merrill A.

The Journal of arthroplasty, 2002-08, Vol.17 (5), p.619-626 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Cilastatin protection against cyclosporin A-induced nephro­toxicity: clinical evidence
Cilastatin protection against cyclosporin A-induced nephro­toxicity: clinical evidence
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cilastatin protection against cyclosporin A-induced nephro­toxicity: clinical evidence

Tejedor, A. ; Torres, A. M. ; Castilla, M. ; Lazaro, J. A. ; Lucas, C. de ; Caramelo, C.

Current medical research and opinion, 2007-03, Vol.23 (3), p.505-513 [Periódico revisado por pares]

Informa UK Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (336)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (348)
  2. Reports  (4)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1992  (23)
  2. 1992Até1999  (52)
  3. 2000Até2007  (101)
  4. 2008Até2016  (89)
  5. Após 2016  (88)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (323)
  2. Japonês  (61)
  3. Português  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.